	Sex-related differences in profiles and clinical outcomes of Inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol Salem DA, El-Ijla R, AbuMusameh RR, Zakout KA, Abu Halima AY, Abudiab MT, Banat YM, Alqeeq BF, Al-Tawil M, Matar K. PMID: 39580396 [PubMed - indexed for MEDLINE]
	Well-differentiated neuroendocrine tumor of the ileal pouch in a patient with ulcerative colitis and primary sclerosing cholangitis: report of a case and review of the literature. Cesk Patol Fabián O, Heribanová A, Drastich P, Voska L. PMID: 39580234 [PubMed - indexed for MEDLINE]
	Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan. Aliment Pharmacol Ther Akiyama S, Shimizu H, Tamura A, Yokoyama K, Sakurai T, Kobayashi M, Eizuka M, Yanai S, Nomura K, Shibuya T, Takahara M, Hiraoka S, Sako M, Yoshida A, Tsuruta K, Yoshioka S, Koroku M, Omori T, Saruta M, Matsumoto T, Okamoto R, Tsuchiya K, Fujii T. PMID: 39578704 [PubMed - as supplied by publisher]
	Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study. Drug Des Devel Ther Alarfaj SJ, Bahaa MM, Elmasry TA, Elberri EI, El-Khateeb E, Hamouda AO, Salahuddin MM, Kamal M, Gadallah AA, Eltantawy N, Yasser M, Negm WA, Hamouda MA, Alsegiani AS, Alrubia S, Eldesoqui M, Abdallah MS. PMID: 39575188 [PubMed - indexed for MEDLINE]
	Effectiveness and safety outcomes after long-term (54â€‰weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II). Therap Adv Gastroenterol Liebert A, K, Michalak A, Cichoz-Lach H, Talar-Wojnarowska R, Domz A, Konecki , Filipiuk A, Krogulecki M, Kopertowska-Majchrzak M, Stawczyk-Eder K, Waszak K, Eder P, Zagórowicz E, Smo, Wojciechowski K, Dryga. PMID: 39575158 [PubMed]
	A novel computational approach for the mining of signature pathways using species co-occurrence networks in gut microbiomes. BMC Microbiol Kim S, Thapa I, Ali H. PMID: 39574009 [PubMed - indexed for MEDLINE]
	Changes in amino acid concentrations and the gut microbiota composition are implicated in the mucosal healing of ulcerative colitis and can be used as noninvasive diagnostic biomarkers. Clin Proteomics Wu J, Li M, Zhou C, Rong J, Zhang F, Wen Y, Qu J, Wu R, Miao Y, Niu J. PMID: 39574001 [PubMed]
	AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology Singh S, Loftus EV Jr, Limketkai BN, Haydek JP, Agrawal M, Scott FI, Ananthakrishnan AN, AGA Clinical Guidelines Committee. Electronic address: clinicalpractice@gastro.org. PMID: 39572132 [PubMed - indexed for MEDLINE]
	Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol D'Haens G, Taxonera C, Lopez-Sanroman A, Nos P, Danese S, Armuzzi A, Roblin X, Peyrin-Biroulet L, West R, Mares WGN, Duijvestein M, Gecse KB, Feagan BG, Zou G, Hulshoff MS, Mookhoek A, Oldenburg L, Clasquin E, Bouhnik Y, Laharie D. PMID: 39571587 [PubMed - as supplied by publisher]
	Validation of the simplified PIBD-classes criteria: A single-center retrospective study. Pediatr Int Miura Y, Hagiwara SI, Hizuka K, Saura R, Hata A, Maeyama T, Etani Y. PMID: 39569836 [PubMed - indexed for MEDLINE]
	Short-term effectiveness and safety of ustekinumab and vedolizumab in elderly and non-elderly patients with Crohn's disease: a comparative study. Therap Adv Gastroenterol Dar L, Shani U, Dotan A, Ukashi O, Ben-Horin S, Kopylov U, Levartovsky A. PMID: 39569055 [PubMed]
	Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning. Front Med (Lausanne) Luo Z, Huang C, Chen J, Chen Y, Yang H, Wu Q, Lu F, Zhang TE. PMID: 39568749 [PubMed]
	Changes in clinical features and seasonal variations of Crohn's disease at diagnosis: a 10-year observational study in China. Front Med (Lausanne) Deng J, Lu Y, Liu T, Zhang M, Yao JY, Zhi M. PMID: 39568741 [PubMed]
	Endoscopic dilation of small-intestine strictures in Crohn's disease by balloon-assisted enteroscopy: a systematic review and meta-analysis. Ann Gastroenterol Moond V, Gill VJS, Malik S, Kasture A, Parajuli S, Soni S, Chandan S, Broder A, Mohan BP, Adler D. PMID: 39568704 [PubMed]
	Correlation between PDGF-BB and M1-type macrophage in inflammatory bowel disease: a case-control study. BMC Gastroenterol Fang Z, Qu S, Ji X, Zheng C, Mo J, Xu J, Zhang J, Shen H. PMID: 39567902 [PubMed - indexed for MEDLINE]
	Partial Enteral Nutrition in the Management of Crohn's Disease: A Systematic Review and Meta-Analysis. J Crohns Colitis Jatkowska A, White B, Gkikas K, Seenan JP, MacDonald J, Gerasimidis K. PMID: 39565924 [PubMed - as supplied by publisher]
	Reviewing the audacity of elixirs of inflammatory bowel disease from mushroom Î²-glucans: The solved and unresolved. Carbohydr Polym Venkatachalam P, Muthu M, Gopal J. PMID: 39562106 [PubMed - indexed for MEDLINE]
	The application of sphingomyelin in mediating the causal role of the T-cell surface glycoprotein CD5 in Crohn's disease: A two-step Mendelian randomization study. Medicine (Baltimore) Li X, Yao X, Wen J, Chen Q, Zhu Z, Zhang X, Wang S, Lan W, Huang Y, Tang S, Zhou X, Han X, Zhang T. PMID: 39560554 [PubMed - indexed for MEDLINE]
	A bidirectional Mendelian randomization study of spleen volume and Crohn disease. Medicine (Baltimore) Song HH, Zhang HR, Hu XR, Jiang XC. PMID: 39560526 [PubMed - indexed for MEDLINE]
	An uncertain future: perspectives of emerging adults with inflammatory bowel disease-a qualitative semistructured interview study in eastern China. BMJ Open Zhou Y, Qiao R, Ding T, Li H, Zhang P. PMID: 39557559 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 52121

Page 1 of 2607



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy